# To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames

> **NCT03975205** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sutphin Drugs** · enrollment: 500 (estimated)

## Conditions studied

- Lymphoma Leukemia

## Interventions

- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT03975205
- **Lead sponsor:** Sutphin Drugs
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975205, "To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03975205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*